WO2008117790A1 - Food/beverage and pharmaceutical composition for oral administration for improvement in acidic urine each comprising fucoidan as active ingredient - Google Patents

Food/beverage and pharmaceutical composition for oral administration for improvement in acidic urine each comprising fucoidan as active ingredient Download PDF

Info

Publication number
WO2008117790A1
WO2008117790A1 PCT/JP2008/055525 JP2008055525W WO2008117790A1 WO 2008117790 A1 WO2008117790 A1 WO 2008117790A1 JP 2008055525 W JP2008055525 W JP 2008055525W WO 2008117790 A1 WO2008117790 A1 WO 2008117790A1
Authority
WO
WIPO (PCT)
Prior art keywords
fucoidan
beverage
food
pharmaceutical composition
active ingredient
Prior art date
Application number
PCT/JP2008/055525
Other languages
French (fr)
Japanese (ja)
Inventor
Ichiro Hisatome
Yasuaki Shirayoshi
Hiroyuki Takeya
Ryota Teshima
Yasunari Miki
Original Assignee
Tottori University
Marine Products Kimuraya Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2008000088A external-priority patent/JP5414995B2/en
Application filed by Tottori University, Marine Products Kimuraya Co., Ltd. filed Critical Tottori University
Priority to US12/530,332 priority Critical patent/US20100048507A1/en
Publication of WO2008117790A1 publication Critical patent/WO2008117790A1/en
Priority to US13/439,936 priority patent/US20120189653A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Disclosed is a food/beverage or a pharmaceutical composition for oral administration for improving an acidic urine, which comprises fucoidan or a fucoidan-containing material as an active ingredient and can increase the pH vale of the urine in a sustained manner. Also disclosed is use of fucoidan or a fucoidan-containing material for the production of the food/beverage or pharmaceutical composition. Further disclosed is a method for improving an acidic urine by increasing the pH value of the urine in a sustained manner, which is characterized by orally administering fucoidan or a fucoidan-containing material.
PCT/JP2008/055525 2007-03-27 2008-03-25 Food/beverage and pharmaceutical composition for oral administration for improvement in acidic urine each comprising fucoidan as active ingredient WO2008117790A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US12/530,332 US20100048507A1 (en) 2007-03-27 2008-03-25 Food/beverage and pharmaceutical composition for oral administration for improvement in acidic urine each comprising fucoidan as active ingredient
US13/439,936 US20120189653A1 (en) 2007-03-27 2012-04-05 Food/beverage and pharmaceutical composition for oral administration for improvement in acidic urine each comprising fucoidan as active ingredient

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2007081453 2007-03-27
JP2007-081453 2007-03-27
JP2008-000088 2008-01-04
JP2008000088A JP5414995B2 (en) 2007-03-27 2008-01-04 Acidic urine-improving food and drink and pharmaceutical composition for oral administration comprising fucoidan as an active ingredient

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/439,936 Division US20120189653A1 (en) 2007-03-27 2012-04-05 Food/beverage and pharmaceutical composition for oral administration for improvement in acidic urine each comprising fucoidan as active ingredient

Publications (1)

Publication Number Publication Date
WO2008117790A1 true WO2008117790A1 (en) 2008-10-02

Family

ID=39788524

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/055525 WO2008117790A1 (en) 2007-03-27 2008-03-25 Food/beverage and pharmaceutical composition for oral administration for improvement in acidic urine each comprising fucoidan as active ingredient

Country Status (1)

Country Link
WO (1) WO2008117790A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013123407A (en) * 2011-12-15 2013-06-24 Shizuka Akizuki 100 percent buckwheat noodle and method for producing the same

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003155244A (en) * 2002-09-13 2003-05-27 Kyodo Milk Industry Co Ltd Food including fucoidan originating from mozuku (edible seaweed)

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003155244A (en) * 2002-09-13 2003-05-27 Kyodo Milk Industry Co Ltd Food including fucoidan originating from mozuku (edible seaweed)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KESSHO K.: "Tusufu no Chiryo Guideline Sakusui Iinkai", JAPANESE SOCIETY OF GOUT AND NUCLEIC ACID METABOLISM, KONYOSAN KESSHO. TSUFU NO CHIRYO GUIDELINE DIGEST-BAN, 1 September 2002 (2002-09-01), pages 10, Retrieved from the Internet <URL:http://www.tufu.or.jp/guidlines.pdf> *
UCHIDA K. ET AL.: "Mozuku Chushutsu Fucoidan no Rat ni Okeru 26-shukan Hanpuku Keiko Toyo Dokusei Shiken Oyobi 4-shukan Kaifuku Shiken", ANNUAL REPORT OF YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH, no. 19, 1999, pages 29 - 46 *
UCHIDA K. ET AL.: "Mozuku Chushutsu Fucoidan no Rat ni Okeru Tankai Oyobi 1-kagetsukan Hanpuku Keiko Toyo Dokusei Shiken", ANNUAL REPORT OF YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH, no. 19, 1999, pages 15 - 28 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013123407A (en) * 2011-12-15 2013-06-24 Shizuka Akizuki 100 percent buckwheat noodle and method for producing the same

Similar Documents

Publication Publication Date Title
EP1893182B8 (en) Oral dosage forms comprising progesterone and method of making and using the same
WO2006039499A3 (en) Method for improving the biovailability of orally delivered therapeutics
WO2009085990A3 (en) Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof
WO2011039768A3 (en) Pharmaceutical compositions for reducing alcohol-induced dose dumping
WO2007142810A3 (en) Methods of using low-dose doxepin for the improvement of sleep
WO2011012322A3 (en) Synthesis and use of vildagliptin for the preparation of pharmaceutical dosage forms
BRPI0513455A (en) flavor masking formulation comprising the drug in a delayed dissolution form and / or cyclodextrin in an improved dissolution form
WO2008107149A3 (en) Pharmaceutical form with impeded abuse
WO2008128115A3 (en) Low-dose doxepin formulations
WO2010088000A3 (en) Antifibrotic compounds and uses thereof
WO2007144169A3 (en) Entacapone-derivatives
WO2005107721A3 (en) Pharmaceutical dosage form comprising pellets as well as its manufacturing process
WO2010097243A3 (en) Process for forming solid oral dosage forms of solifenacin and its pharmaceutically acceptable salts
WO2006060681A3 (en) Pharmaceutical composition containing an anti-nucleating agent
WO2007031887A3 (en) Extended release pharmaceutical composition of metformin and a process for producing it
WO2007016284A3 (en) Pharmaceutical formulations/composition of guanfacine suitable for single dose form adminstration daily
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
WO2009045795A3 (en) Galenical formulations of aliskiren and valsartan
WO2010012459A3 (en) A process for the preparation of solifenacin salts and their inclusion into pharmaceutical dosage forms
WO2007131070A3 (en) Compositions, dosage forms and methods of treating emesis
WO2007133796A3 (en) Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist
WO2010046933A3 (en) Pharmaceutical compositions of taste-masked linezolid
WO2007083190A3 (en) Water insoluble helichrysum extract, process for preparing the same and uses thereof
WO2012085249A3 (en) Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts together with an organic acid
JP2008266291A5 (en)

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08738820

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 12530332

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08738820

Country of ref document: EP

Kind code of ref document: A1